Probiotic specialist Culturelle is witnessing strong growth in China for its products targeted at women’s intimate health and weight management, alongside products for digestion.
US-based Prolacta Bioscience, best known for its human milk-based nutritional fortifiers, is conducting a clinical trial assessing the effect of its products on the growth of premature infants in Japan.
This round-up features new innovations in the Indian market with a focus on botanicals and plant-based ingredients to address liver, lung, cognitive health issues, rheumatoid arthritis, as well as the growth potential of the hemp industry.
Australian healthcare company EZZ Life Science Holdings is pressing on with ambitious R&D and international expansion plans, as it shifts from being a distributor to a producer of evidence-based health products.
A Singapore company has launched a bio-optimised marine collagen targeting medical aesthetic and general practitioner clinics as distribution channels.
A new vegan supplement brand from India is seeking to tackle health categories that it believes have so far been overlooked, such as the lack of vegan offerings for liver and lung health.
There are a number of scientific reports which claim that there is a high rate of anaemia among the Indian population, but the latest guest of our NutraChampion podcast argues that this may not be the case and there may even be an “overdiagnosis” of anaemia...
Regulator Food Standards Australia New Zealand is seeking public comment on the use of 2’-O-fucosyllactose (2’-FL) produced using new genetically modified (GM) strains in infant formula products.
South Korean regulator the Ministry of Food and Drug Safety (MFDS) is removing spirulina’s skin health functional claim and has also changed the requirements of eight other raw materials.
A new start-up from China, Ortu, has released a clean label skin health supplement on Tmall said to cater to all genders, ages and skin colours, and eschewing the traditional lightening claims.
